Understanding Epitalon
Epitalon is an AEDG tetrapeptide discussed in aging, telomere, and circadian research. The source distinguishes older research programmes and community cycles from a large blinded human injection trial, which it does not identify.
Peptide Type
AEDG tetrapeptide
Research Areas
Aging, telomere, and circadian research
Reported Administration Route
Subcutaneous (SC)
Reported Short Course A
5 mg/day for 20 days
Reported Short Course B
10 mg/day for 10 days
Reported Repeat Frequency
Two or three times per year; quick-start text instead says one or two times per year.
Important Research Limitation
These inconsistent community conventions are not a proven human telomere regimen. Epitalon should not be confused with related extracts.
Reported Epitalon Schedules
The source describes two reported short-course schedules and inconsistent repeat-frequency conventions. These are reported examples, not established human treatment guidance.
SC example
Per administration
Frequency
Daily total
Reported cycle
Reported Short Course A
5 mg
Daily
5 mg/day
20 days
Reported Short Course B
10 mg
Daily
10 mg/day
10 days
Repeat Frequency
Not specified in source
Not specified in source
Not specified in source
Two or three times/year; quick-start text says one or two times/year.
Per administration
Not specified in source
Frequency
Not specified in source
Daily total
Not specified in source
Reported cycle
Two or three times/year; quick-start text says one or two times/year.
The source reports inconsistent repeat-frequency conventions. These schedules are not a proven human telomere regimen.
Reported Use Does Not Establish Efficacy
The source does not identify a large blinded human injection trial establishing Epitalon benefits. Community schedules should not be interpreted as clinically validated regimens.
Safety & Research Limitations
Human safety and efficacy information is limited. Telomere findings do not establish lifespan extension.
Important Research Concerns
Storage & Handling Information
Powder Storage
Source recommends storage at -20°C.
Mixed Product Storage
Keep refrigerated and protected from light.
Monitoring Considerations
Sleep and circadian observations.
Product Identification
Distinguish Epitalon from related extracts.
Epitalon Concentration Calculator
Example calculation values from the source. These are not mixing or administration instructions.
Amount (mg)
Final volume (mL)
Concentration (mg/mL)
Per 1 U (mcg)
Per 10 U (mcg)
U means a U-100 volume marking: 1 U = 0.01 mL. For a blend, total mass is not the amount of each ingredient. Separate-component arithmetic remains separate. These inputs are examples, not mixing or administration instructions.
What the Research Shows
Mortality findings often concern epithalamin extract, sometimes with thymalin, rather than isolated synthetic AEDG. No large blinded injection trial establishes Epitalon longevity benefit.
Extract-Specific Findings
Mortality findings often concern epithalamin extract rather than isolated synthetic AEDG.
Related Peptide Combinations
Some findings involve epithalamin used with thymalin.
Limited Human Injection Evidence
No large blinded human injection trial establishes Epitalon longevity benefit.
Regulatory & Research Status
Regulatory Status Not Specified
The source does not provide a verified current regulatory status for Epitalon / Epithalon.
No current regulatory approval details are specified in the source.
